Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,915,865
-$100,747 QoQ
Shares Held
33,250
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#856
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ceeto Capital Group, LLC holds $22,200,435 across 8 Drug Manufacturers - General names. BMY ranks #6 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,290 | $5,105,775 | |
| 2 | MRK |
Merck & Co., Inc.
|
29,864 | $3,837,524 | |
| 3 | LLY |
ELI LILLY & Co
|
3,030 | $3,634,273 | |
| 4 | AMGN |
Amgen Inc
|
9,675 | $3,503,511 | |
| 5 | JNJ |
Johnson & Johnson
|
8,418 | $2,137,919 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
33,250 | $1,915,865 | |
| 7 | PFE |
Pfizer Inc
|
53,250 | $1,282,260 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,200 | $783,308 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,915,865 | 33,250 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,016,612 | 33,250 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,793,505 | 33,250 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,551,079 | 34,392 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,539,142 | 33,250 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,027,917 | 33,250 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,880,620 | 33,250 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,565,135 | 30,250 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,204,370 | 29,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,675,707 | 30,900 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,487,990 | 29,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,659,944 | 28,600 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $1,790,600 | 28,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,906,025 | 27,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,942,650 | 27,000 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $1,919,430 | 27,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,310,000 | 30,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,190,900 | 30,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,870,500 | 30,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,775,100 | 30,000 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,205,060 | 33,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,083,290 | 33,000 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,984,960 | 32,000 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,929,280 | 32,000 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,911,000 | 32,500 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,811,550 | 32,500 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||